Medical News

Viral Reservoir in Early-Treated HIV-Infected Children and...
Nutr Metab
Lower viral reservoir was associated with starting ART at <1 week. Negative serostatus and qualitative DNA were...
22 Feb 2021

Weight Gain Following ART Initiation in ART-Naïve People Liv...
JAIDS
There is heterogeneity between regimens in weight gain following ART initiation among previously ART-naïve PLWH; we...
12 Feb 2021

Differences in Types of Myocardial Infarctions Among People...
JAIDS
Rates of T2MIs were higher than T1MIs until age 40 years among PLWH, differing from the general population, but...
09 Feb 2021

Immunodeficiency and Cancer in 3.5 Million People Living wit...
Clin Infect Dis
Lower CD4 cell counts were associated with an increased risk of developing various infection-related cancers among...
03 Feb 2021
eCMEs
Key Trials
Efficacy of Reduced Doses of both TDF and EFV for the Treatment of HIV-1 Infection
This study is the first randomized, controlled trial in an antiretroviral-naive population that evaluated the efficacy of reduced doses of both...
144-week Efficacy and Safety of Fixed-dose Combination Bictegravir, Emtricitabine, and Tenofovir alafenamide versus Dolutegravir-containing Regimens for Initial Treatment of HIV-1 Infection
This is a randomised, double-blind, multicentre, phase 3 trial evaluating 144-week efficacy and safety of fixed-dose combination bictegravir,...
Long Acting Injectables (CAB+RPV) for HIV Maintenance Therapy: Week 48 Pooled Analysis of Phase III ATLAS and FLAIR Studies
The present study is the pooled analysis of two phase III studies, ATLAS and FLAIR, that compared efficacy and safety of monthly intramuscular (IM)...
ADVANCE Trial: 96-week Efficacy and Safety of DTG Combined with FTC and TAF or TDF versus EFV Combined with FTC and TDF
The ADVANCE trial compared the efficacy and safety of a triple-therapy combination of emtricitabine and dolutegravir plus either of two tenofovir...
Our Publications
Antiretroviral-based Prevention Strategies in HIV
Today, antiretroviral therapy (ART) is not only known to keep HIV-infected patients alive but is also being harnessed as a strategy to prevent...
Antiretroviral Therapy – Current Recommendations
Advances in the treatment of HIV infection has resulted in a dramatic shift, from a deadly infectious disease to a chronic manageable condition....
Datasheet: Lopinavir and Ritonavir (40mg/10mg) Oral Pellets
Lopinavir and Ritonavir (40 mg / 10 mg) Oral Pellets is a Novel oral pellet formulation for paediatric use. This datasheet contains the entire...
Fast Facts: Lopinavir and Ritonavir (40 mg/10 mg) Oral Pellets
Lopinavir and Ritonavir (40 mg / 10 mg) Oral Pellets is a Novel oral pellet formulation for paediatric use. This booklet contains information about...
Patient Education
Live Healthier, Live Longer
This publication features commonly asked questions by HIV patients regarding HIV therapy, drug side-effects, Do’s and Don’ts while on HIV treatment....
Living with Hope
This publication features common questions which arise in HIV patients mind regarding HIV, diagnosis, transmission, treatment and drug side effects. ...